PMV Pharmaceuticals, Inc. Contracts & Agreements
39 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (1)
- Human Resources (28)
- Real Estate (2)
- Uncategorized (2)
- 2020 Employee Stock Purchase Plan and forms of agreements thereunder (Filed With SEC on May 9, 2024)
- Amended Outside Director Compensation Policy (Filed With SEC on February 29, 2024)
- Consulting Agreement, dated January 5, 2024, by and between the Registrant and Winston Kung (Filed With SEC on February 29, 2024)
- Separation Agreement, dated January 5, 2024, by and between the Registrant and Leila Alland, M.D (Filed With SEC on February 29, 2024)
- Amended and Restated Employment Letter, dated January 5, 2024, by and between the Registrant and Michael Carulli (Filed With SEC on February 29, 2024)
- Consulting Agreement, dated February 13, 2024, by and between the Registrant and Charles Baum, MD., Ph.D (Filed With SEC on February 29, 2024)
- Outside Director Compensation Policy., as amended on May 5, 2022 (Filed With SEC on August 9, 2022)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated March 24, 2022, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on May 10, 2022)
- Employment Offer Letter, dated February 22, 2021, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on March 1, 2022)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated January 14, 2022, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on March 1, 2022)
- PMV PHARMACEUTICALS, INC. AMENDED & RESTATED SAB CONSULTING AGREEMENT (Filed With SEC on March 1, 2022)
- Open Market Sale Agreement, between the Company and Jefferies LLC, dated as of October 4, 2021 (Filed With SEC on October 5, 2021)
- Description of Securities of the Registrant (Filed With SEC on March 3, 2021)
- Lease Agreement, dated January 8, 2021, by and between the Registrant and BMR-ONE RESEARCH WAY LLC (Filed With SEC on March 3, 2021)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on September 21, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on September 21, 2020)
- 2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 21, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect prior to the completion of this offering (Filed With SEC on September 21, 2020)
- 2020 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on September 21, 2020)
- Outside Director Compensation Policy (Filed With SEC on September 21, 2020)
- Amended and Restated Investors Rights Agreement, dated July 17, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on September 4, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on September 4, 2020)
- 2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 4, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect prior to the completion of this offering (Filed With SEC on September 4, 2020)
- 2020 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 17, 2020, by and between the Registrant and David H. Mack, Ph.D (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 17, 2020, by and between the Registrant and Winston Kung (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 18, 2020, by and between the Registrant and Leila Alland, M.D (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 18, 2020, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on September 4, 2020)
- Employee Incentive Compensation Plan (Filed With SEC on September 4, 2020)
- Change in Control and Severance Policy (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 17, 2020, by and between the Registrant and David H. Mack, Ph.D (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 17, 2020, by and between the Registrant and Winston Kung (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 18, 2020, by and between the Registrant and Leila Alland, M.D (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 18, 2020, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on September 4, 2020)
- Outside Director Compensation Policy (Filed With SEC on September 4, 2020)
- Consulting Agreement, dated January 1, 2016, by and between the Registrant and Arnold Levine, Ph.D (Filed With SEC on September 4, 2020)
- Consulting Agreement, dated July 14, 2017, by and between the Registrant and Richard Heyman, Ph.D (Filed With SEC on September 4, 2020)
- Lease Agreement, dated March 3, 2015, by and between the Registrant and Cedar Brook 2005, LP, as amended by the First Amendment to Lease dated April 24, 2017 (Filed With SEC on September 4, 2020)
